TWD 83.5
(2.2%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 509.11 Million | -21.71 Million | -108 Million | 240.25 Million | - |
Net Income | 220.58 Million | 1.75 Million | -106.17 Million | 114.11 Million | - |
Depreciation & Amortization | 29.67 Million | 29.87 Million | 31.22 Million | 28.35 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 1.71 Million | - | - | 729 Thousand | - |
Change in working capital | 309.57 Million | -42.65 Million | -18.51 Million | 36.02 Million | - |
Other non-cash items | -3.09 Million | 45.15 Million | 3.56 Million | 20.56 Million | - |
Investing Cash Flow | -56.88 Million | -6.17 Million | 82.06 Million | 64.12 Million | - |
Investments in PPE | -37.33 Million | -24.74 Million | -2.2 Million | -23.46 Million | - |
Acquisitions | 598 Thousand | - | - | - | -300 Thousand |
Investment purchases | -107.42 Million | -9.5 Million | - | -24.19 Million | - |
Sales/Maturities of investments | 88.07 Million | 26.86 Million | 72.26 Million | 117.4 Million | - |
Other Investing Activities | -1.26 Million | -265 Thousand | 7.95 Million | -5.77 Million | - |
Financing Cash Flow | 84.15 Million | 775 Thousand | -143.93 Million | -40.24 Million | - |
Debt repayment | -13.29 Million | -7.28 Million | -2.46 Million | -5.88 Million | - |
Dividends payments | -15 Million | - | -135 Million | -125.23 Million | -50.6 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 118.84 Million | - | - | 97.65 Million | - |
Other Financing Activities | -6.4 Million | - | - | -800 Thousand | - |
Accounts receivables | 9.71 Million | - | - | - | - |
Accounts payables | 29.23 Million | - | - | - | - |
Inventory | -13.33 Million | 573 Thousand | -385 Thousand | 1.08 Million | - |
Other working capital | 313.19 Million | - | - | - | - |
Cash at beginning of period | 172.75 Million | 194.05 Million | 370.53 Million | 106.55 Million | - |
Cash at end of period | 710.12 Million | 172.75 Million | 194.05 Million | 370.53 Million | - |
Capital Expenditure | -37.33 Million | -24.74 Million | -2.2 Million | -23.46 Million | - |
Effect of forex changes on cash | 989 Thousand | 5.8 Million | -6.6 Million | -153 Thousand | - |
Net cash flow / Change in cash | 537.37 Million | -21.3 Million | -176.48 Million | 263.98 Million | - |
Free Cash Flow | 471.78 Million | -46.45 Million | -110.2 Million | 216.79 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 34.37 Million | 91.59 Million | 220.58 Million | 100.86 Million | 81.03 Million | 9.52 Million |
Depreciation & Amortization | 7.31 Million | 7.47 Million | 29.67 Million | 7.89 Million | 8.03 Million | 6.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 1.71 Million | 1.71 Million | - | - |
Change in working capital | -100.93 Million | -135.46 Million | 309.57 Million | 213.31 Million | 47.16 Million | -1.59 Million |
Other non-cash items | -1.8 Million | -1.86 Million | -3.09 Million | -1.65 Million | -561 Thousand | -686 Thousand |
Investing Cash Flow | 73.05 Million | -223.72 Million | -56.88 Million | -105.96 Million | 30.86 Million | 23.02 Million |
Investments in PPE | -13.73 Million | -5.34 Million | -37.33 Million | -2.74 Million | -1.48 Million | -31.1 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | 83.12 Million | -216.74 Million | -107.42 Million | -101.22 Million | 5.97 Million | 15.39 Million |
Sales/Maturities of investments | 1.27 Million | - | 88.07 Million | -2.18 Million | 32.78 Million | 37.09 Million |
Other Investing Activities | 3.5 Million | -1.63 Million | -1.26 Million | 185 Thousand | -7.47 Million | 1.63 Million |
Financing Cash Flow | -143.89 Million | -5.18 Million | 84.15 Million | 113.32 Million | -18.95 Million | -5.11 Million |
Debt repayment | -32.63 Million | -3.53 Million | -13.29 Million | -3.93 Million | -2.33 Million | -3.51 Million |
Dividends payments | -174.9 Million | - | -15 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 118.84 Million | - | - | - |
Other Financing Activities | -1.63 Million | - | - | - | - | - |
Accounts receivables | 696 Thousand | - | - | - | - | - |
Accounts payables | -44.7 Million | - | - | - | - | - |
Inventory | 937 Thousand | 464 Thousand | -13.33 Million | 401 Thousand | 11.82 Million | -25.74 Million |
Other working capital | -70 Million | - | - | - | - | - |
Cash at beginning of period | 441.77 Million | 710.12 Million | 172.75 Million | 380.41 Million | 243.4 Million | 221.55 Million |
Cash at end of period | 304.08 Million | 441.77 Million | 710.12 Million | 710.12 Million | 380.41 Million | 243.4 Million |
Capital Expenditure | -13.73 Million | -5.34 Million | -37.33 Million | -2.74 Million | -1.48 Million | -31.1 Million |
Effect of forex changes on cash | -213 Thousand | -327 Thousand | 989 Thousand | 872 Thousand | 340 Thousand | -201 Thousand |
Net cash flow / Change in cash | -137.69 Million | -268.34 Million | 537.37 Million | 329.7 Million | 137.01 Million | 21.85 Million |
Free Cash Flow | -80.37 Million | -44.45 Million | 471.78 Million | 318.73 Million | 123.27 Million | -26.95 Million |
VOE
FIVE
PPLPHARMA
300888
ARMK
NNDNF